NEW YORK & VISTA, Calif.--(BUSINESS WIRE)--Paige, a global leader in end-to-end digital pathology solutions and clinical AI applications, and Leica Biosystems, a cancer diagnostics company and global ...

The MarketWatch News Department was not involved in the creation of this content. Collaboration accelerates Leica Biosystems' offering to create a unified, AI-ready platform for the development and ...

MINNEAPOLIS, April 2, 2025 /PRNewswire/ -- Bio-Techne Corporation (NASDAQ: TECH) today announced an expansion of the longstanding partnership between its spatial biology brand, Advanced Cell ...

CAMBRIDGE, Mass., Jan. 31, 2022 /PRNewswire/ -- Leica Biosystems, a cancer diagnostics company, has entered into an agreement with Leap Therapeutics (NASDAQ: LPTX), a biotechnology company, to develop ...

Leica Biosystems has announced an affiliate has agreed to acquire Aperio, according to a news release. Aperio is a provider of ePathology solutions based in Vista, Calif. Following the acquisition, ...

Visualizes functional protein-protein interactions directly within fixed tissue at subcellular resolution Enables simultaneous detection of protein proximity, RNA, and proteins on the same tissue ...

Cell Signaling Technology (CST), a life science discovery technology company and leading provider of antibodies, kits, and services, is partnered with Leica Biosystems, a technology leader in ...

It’s an Open House! Come join us virtually where you will have the opportunity to network with colleagues and learn about the latest developments in life science research. The Leica Biosystems ...

Here is your opportunity to be part of the discussion and explore the new research capabilities on the Leica Biosystems BOND RX Fully Automated Research Stainer. In recent years, there are many ...

VISTA, Calif., Dec. 9, 2025 /PRNewswire/ -- Leica Biosystems, a Danaher company and a global leader in anatomic pathology solutions, is driving the future of clinical diagnostics with another bold ...

Collaboration accelerates Leica Biosystems' offering to create a unified, AI-ready platform for the development and deployment of efficient workflows across the entire pathology lab VISTA, Calif. and ...